China Digest: GenFleet, ABM Therapeutics in funding news

Innovative Drugs

Clinical-stage healthcare firms GenFleet Therapeutics and ABM Therapeutics have raked in $79 million and $30 million, respectively.

Genfleet nets $79m in Series C round 

Clinical-stage biotechnology firm GenFleet Therapeutics has garnered nearly 500 million yuan ($79 million) in its Series C round of financing, per a company statement on Tuesday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter